Search

everythinglearnresearchcommunity

for

Search:↓

The study has limitations, and future research should use better methods to improve treatment for children with hair loss.

Astragalus sinicus extracts may help promote hair growth and treat hair loss.

Androgenic Alopecia, a common hair loss condition, can be effectively treated with finasteride and other treatments.

Trichoscan is a reliable method for measuring hair growth and monitoring treatment effectiveness in hair loss.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

The research identified genes and non-coding RNAs in cells that could be affected by testosterone, which may help understand hair loss and prostate cancer.

Androgens, male hormones, affect physical and mental functions, with a decrease leading to health issues like muscle loss, bone disease, and depression, and more research is needed on long-term effects and treatments.

The study found new details about human hair growth and suggests that preventing a specific biological pathway could potentially treat hair graying.

Early hair loss may indicate prostate issues.

People with early hair loss may have a higher chance of enlarged prostate and metabolic syndrome, so they should be checked for urinary and metabolic issues.

Liver disease is linked to hair loss, especially in women and those with unhealthy lifestyles.

Hair loss may indicate higher heart risk and metabolic issues.

Finasteride helps reduce heart issues and improves heart function.

Hair loss in women linked to higher sexual dysfunction risk.

Hair loss can indicate brain aging and potential small vessel disease, but more research is needed to understand the clinical impact.

Finasteride may cause kidney damage.

Androgenetic alopecia is mainly caused by genetic factors and increased androgen activity, leading to hair follicle miniaturization.

Minoxidil might partially activate estrogen receptors, affecting hair growth.

Male pattern baldness involves genetics, hormones, and needs better treatments.

Prostaglandins and the enzyme AKR1C3 could play a role in skin cancer and hair loss, and further research is needed to understand these mechanisms.

Postmenopausal hyperandrogenism, a condition with symptoms like increased hair growth and acne, is usually caused by PCOS but can also be due to other factors. It's diagnosed by checking testosterone levels and treated either by removing the adrenal tumor or through antiandrogen therapy.

Men with male pattern baldness have a higher risk of aggressive prostate cancer and benign prostatic hyperplasia.

Diffuse alopecia in women may be related to androgens and iron deficiency, and basic hormone and nutrient screening is useful.

Current treatments for male pattern baldness include minoxidil and finasteride, with new options being developed.

Platelet-rich plasma treatment significantly increased hair diameter and density, stopped hair fall, and boosted hair growth in men with hair loss, with no reported side effects.

Metabolic syndrome linked to urinary symptoms; hair loss not significant.

Higher testosterone and DHEA-S levels may be linked to male pattern baldness.

Serum biomarkers like insulin-like growth factor-1 and vitamin D may help diagnose androgenetic alopecia.

Normal levels of DHT can reduce belly fat and increase muscle, but too much can lead to hair loss, prostate issues, and possibly heart disease.

PNU 157706 is a more effective treatment than finasteride for conditions caused by DHT, like enlarged prostate and hair loss.